Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wheezing is common in children with sickle cell disease when compared with controls.
Galadanci NA, Liang WH, Galadanci AA, Aliyu MH, Jibir BW, Karaye IM, Inusa BP, Vermund SH, Strunk RC, DeBaun MR. Galadanci NA, et al. Among authors: galadanci aa. J Pediatr Hematol Oncol. 2015 Jan;37(1):16-19. doi: 10.1097/MPH.0000000000000239. J Pediatr Hematol Oncol. 2015. PMID: 25197776 Free PMC article.
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
Abdullahi SU, Wudil BJ, Bello-Manga H, Musa AB, Gambo S, Galadanci NA, Aminu H, Tijjani Gaya A, Sanusi S, Tabari MA, Galadanci A, Borodo A, Abba MS, Dambatta AH, Haliru L, Gambo A, Cassell H, Rodeghier M, Ghafuri DL, Covert Greene BV, Neville K, Kassim AA, Kirkham F, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Among authors: galadanci a, galadanci na. Pediatr Hematol Oncol. 2021 Feb;38(1):49-64. doi: 10.1080/08880018.2020.1810183. Epub 2020 Nov 25. Pediatr Hematol Oncol. 2021. PMID: 33236662 Free PMC article. Clinical Trial.
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
Galadanci AA, Galadanci NA, Jibir BW, Abdullahi SU, Idris N, Gambo S, Ali Abubakar SA, Kabo NA, Bello-Manga H, Haliru L, Bashir I, Aliyu MH, Galadanci JA, DeBaun MR. Galadanci AA, et al. Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11. Am J Hematol. 2019. PMID: 31423630 Free PMC article. No abstract available.
Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
Bello-Manga H, Galadanci AA, Abdullahi S, Ali S, Jibir B, Gambo S, Haliru L, Jordan LC, Aliyu MH, Rodeghier M, Kassim AA, DeBaun MR, Galadanci NA. Bello-Manga H, et al. Among authors: galadanci aa. Br J Haematol. 2020 Sep;190(6):939-944. doi: 10.1111/bjh.16746. Epub 2020 May 16. Br J Haematol. 2020. PMID: 32415792 Free PMC article. Clinical Trial.
High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
Idris IM, Yusuf AA, Gwarzo DH, Kurawa MS, Shuaib A, Galadanci AA, Ibrahim H, Borodo AM, Jobbi YD, Danagundi MB, Borodo SB, Mohammed IY, Galadanci NA, Kuliya-Gwarzo A. Idris IM, et al. Among authors: galadanci aa. Hemoglobin. 2021 Jul;45(4):228-233. doi: 10.1080/03630269.2021.1957927. Epub 2021 Aug 6. Hemoglobin. 2021. PMID: 34353203
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.
Abdullahi SU, Jibir BW, Bello-Manga H, Gambo S, Inuwa H, Tijjani AG, Idris N, Galadanci A, Hikima MS, Galadanci N, Borodo A, Tabari AM, Haliru L, Suleiman A, Ibrahim J, Greene BC, Ghafuri DL, Rodeghier M, Slaughter JC, Kirkham FJ, Neville K, Kassim A, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Lancet Haematol. 2022 Jan;9(1):e26-e37. doi: 10.1016/S2352-3026(21)00368-9. Lancet Haematol. 2022. PMID: 34971579 Free PMC article. Clinical Trial.
Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
Galadanci NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, Aminu H, Tijjani A, Abba MS, Tabari MA, Galadanci A, Borodo AM, Belonwu R, Salihu AS, Rodeghier M, Ghafuri DL, Covert C Greene BV, Neville K, Kassim AA, Kirkham FJ, Jordan LC, Aliyu MH, DeBaun MR. Galadanci NA, et al. Among authors: galadanci a. Am J Hematol. 2020 Sep;95(9):E247-E250. doi: 10.1002/ajh.25900. Epub 2020 Jul 10. Am J Hematol. 2020. PMID: 32510680 Free PMC article. Clinical Trial. No abstract available.